Fig. 3

Relationship between the patient subgroups classified by PPM1H protein expression and survival outcomes in the validation data set. (a) Represented protein expression of cytoplasmic PPM1H; (b) DFS analysis between patient subgroups with high or low PPM1H protein expression; (c) DSS analysis between patient subgroups with high or low PPM1H protein expression. The red bar in the figure represents 100 μM. DFS, disease-free survival; DSS, disease-specific survival